Multiple Sclerosis: The most common neurodegenerative disease
Nowadays, Multiple Sclerosis (MS) is central nervous system disease which is incurable and progressive, and it affects women more than men between the ages of 20 and 30. The MS is not a contagious or deadly disease, but it prevails in young people’s life. The diagnosis of multiple sclerosis, since is a neurodegenerative disease, is a blow to the affected person, who sees how his or her world, somehow, has to reinvent itself. The person begins a new life to which it is necessary to adapt and to give form, knowing the personal limitations. The patients highlight the uncertainty of not knowing when the next outbreak will be, nor the sequels that will leave, nor what will be their situation after a few years. Symptoms like fatigue does not help, either. It is a reality that only those affected who live day by day with the disease know, that teaches them to put in value experiences, sensations and capacities that previously went completely unnoticed.
And so, many people with MS continue to have a normal life and can go through long periods without developing symptoms. After the initial diagnosis and during the first months of therapy, patients with multiple sclerosis have many doubts, not only regards to the disease and its impact on their future life, but also regards to aspects of daily therapy. But what is MS? Multiple sclerosis chronic inflammatory sickness of the central nervous mechanism which causes the demyelination of nerve cells and the formation of plaques of scar tissue called sclerosis. These plaques can be seen in the brain, marrow and brain stem.
Moreover, the MS can be considered as an autoimmune illness since the body reacts by creating antibodies that also attack the body’s own cells. These antibodies remain in the blood because of the infection, developing chronic diseases that usually evolve by outbreaks, and can affect different organs and tissues. In Multiple Sclerosis the nerve tissue called myelin is affected. Myelin is a fatty chemical that protects and surrounds neurological fabric, which will help drive the neural impulse. When myelin is lost, the nerve impulse decreases or disappears. When multiple sclerosis is detected at an early stage, the myelin sheaths are the first to become inflamed at certain points. If so, inflammation can be corrected with treatments based in stem cells. However, when the sheaths are very damage the goal of this kinds of therapy is to reduce symptoms to improve the patient’s life quality.
At the same time, the lesions in the nerve fibers are progressive, but no two patients are the same and in each of them, the disease will evolve unpredictably and individually. Thus, in some patients it can be relatively mild and in others it is incapacitating or devastating. Some people who have MS may be lightly affected, although some others may lose the capability to write, talk or move when connection involving the brain as well as other parts of the body is interrupted.
And so, because the course of the disease varies greatly from one patient to another, it can occur in outbreaks, with partial or complete remission or progressively. The Outbreak forms evolve into secondarily progressive forms. For this reason there are patients who remain practically asymptomatic after long years of evolution, while others have frequent outbreaks and marked progressive deterioration or even a fulminating course that leads to death.
Multiple sclerosis manifests itself through numerous symptoms because the disease does not have a single evolution. However, there are some early symptoms that often occur. Some of the first discomforts that appear are numbness, alterations of vision and muscular paralysis. As well as spasticity, fatigue, depression and dizziness as the illness progresses. And, about half of the patients also present cognitive disorders that are usually mild and difficult to detect, and which show itself as troubles in memory, concentration and attention.
Multiple sclerosis has no cure but there are strategies that can modify the course of the disease, treat exacerbations, control symptoms and improve function and mobility. Treatments with stem cells have been proved that the can help patients to reduce symptom. The stem cells have the ability to create more cells in the body´s system, so they are able to regenerate the damage in the nerve fibers. At the same time, stem cells can help the body to decrease inflammation, improving conduction through the demyelinated areas.
Our company has a great stem cell therapy which is applied through blisters and ampoules for patient comfort. It not only adds to patient’s body a nutritional support to compensate the lack of protein nutrients, but it also help to reduce symptoms in early stages of the disease. Do not hesitate in contact us via email, or to our phones for more information that we will be happy to help you.